Citations 2

A Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache: Results from the 8-Week Double-Blind Treatment Phase (Plen02.004)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.plen02.004

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

New England Journal of Medicine | July 10, 2019 | Volume: 381 | Issue: 2 | Pages: 132-141

10.1056/nejmoa1813440 | PMID 31291515